Biolase (BIOL +36%) shares are soaring after the company received 510(k) clearance from the FDA...

|By:, SA News Editor

Biolase (BIOL +36%) shares are soaring after the company received 510(k) clearance from the FDA for its EPIC 10 diode soft tissue laser, and began immediately offering the device for sale in the U.S. The company also received CE Mark approval for the laser in the European Union and began commercial sales there, as well as in Asian and Latin American countries that also recognize the CE Mark, during the final few days of its Q3.